Young infants produce strong immune response to SARS-CoV-2, study finds
Press release issued: 17 June 2021
Young infants show strong immune responses to SARS-CoV-2, new research has found. In particular, compared with adults, young infants produce relatively high levels of antibodies and immune cells that can specifically protect against COVID-19.
Dr Anu Goenka, Clinical Lecturer in Paediatric Infectious Diseases and Immunology at the University of Bristol and Bristol Royal Hospital for Children, said: “By conducting a detailed study on young infants who are relatively protected from severe COVID-19, we have shown what protective immunity 'looks like’, in terms of the make-up of specific antibodies and immune cells directed against SARS-CoV-2.
“This is very useful information for the design of future COVID-19 vaccines that could seek to induce and mimic the signature of this protective immunity.”
‘Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2’ by Anu Goenka et al in Cell Reports Medicine [open access]
For the full story visit the University of Bristol website.